These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 25421998

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
    Mei F, Mayoral SR, Nobuta H, Wang F, Desponts C, Lorrain DS, Xiao L, Green AJ, Rowitch D, Whistler J, Chan JR.
    J Neurosci; 2016 Jul 27; 36(30):7925-35. PubMed ID: 27466337
    [Abstract] [Full Text] [Related]

  • 4. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ.
    Nature; 2015 Jun 11; 522(7555):216-20. PubMed ID: 25896324
    [Abstract] [Full Text] [Related]

  • 5. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO.
    Adv Exp Med Biol; 2017 Jun 11; 958():91-127. PubMed ID: 28093710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cell reprogramming for oligodendrocytes: A review of protocols and their applications to disease modeling and cell-based remyelination therapies.
    McCaughey-Chapman A, Connor B.
    J Neurosci Res; 2023 Jun 11; 101(6):1000-1028. PubMed ID: 36749877
    [Abstract] [Full Text] [Related]

  • 8. Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
    Kremer D, Göttle P, Hartung HP, Küry P.
    Trends Neurosci; 2016 Apr 11; 39(4):246-263. PubMed ID: 26964504
    [Abstract] [Full Text] [Related]

  • 9. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation.
    Wang Y, Piao JH, Larsen EC, Kondo Y, Duncan ID.
    J Neurosci Res; 2011 Nov 11; 89(11):1737-46. PubMed ID: 21793039
    [Abstract] [Full Text] [Related]

  • 10. Platelet-derived growth factor-responsive neural precursors give rise to myelinating oligodendrocytes after transplantation into the spinal cords of contused rats and dysmyelinated mice.
    Plemel JR, Chojnacki A, Sparling JS, Liu J, Plunet W, Duncan GJ, Park SE, Weiss S, Tetzlaff W.
    Glia; 2011 Dec 11; 59(12):1891-910. PubMed ID: 22407783
    [Abstract] [Full Text] [Related]

  • 11. Signalling pathways that inhibit the capacity of precursor cells for myelin repair.
    Sabo JK, Cate HS.
    Int J Mol Sci; 2013 Jan 07; 14(1):1031-49. PubMed ID: 23296277
    [Abstract] [Full Text] [Related]

  • 12. Oligodendrogenesis from neural stem cells: perspectives for remyelinating strategies.
    Grade S, Bernardino L, Malva JO.
    Int J Dev Neurosci; 2013 Nov 07; 31(7):692-700. PubMed ID: 23340483
    [Abstract] [Full Text] [Related]

  • 13. Cellular approaches for stimulating CNS remyelination.
    Miller RH, Bai L.
    Regen Med; 2007 Sep 07; 2(5):817-29. PubMed ID: 17907933
    [Abstract] [Full Text] [Related]

  • 14. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
    Mothe AJ, Tator CH.
    Exp Neurol; 2008 Sep 07; 213(1):176-90. PubMed ID: 18586031
    [Abstract] [Full Text] [Related]

  • 15. From demyelination to remyelination: the road toward therapies for spinal cord injury.
    Papastefanaki F, Matsas R.
    Glia; 2015 Jul 07; 63(7):1101-25. PubMed ID: 25731941
    [Abstract] [Full Text] [Related]

  • 16. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain.
    Paez PM, Cheli VT, Ghiani CA, Spreuer V, Handley VW, Campagnoni AT.
    Glia; 2012 Jul 07; 60(7):1078-93. PubMed ID: 22447683
    [Abstract] [Full Text] [Related]

  • 17. A functional role for EGFR signaling in myelination and remyelination.
    Aguirre A, Dupree JL, Mangin JM, Gallo V.
    Nat Neurosci; 2007 Aug 07; 10(8):990-1002. PubMed ID: 17618276
    [Abstract] [Full Text] [Related]

  • 18. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites.
    Mecha M, Feliú A, Carrillo-Salinas FJ, Mestre L, Guaza C.
    Exp Neurol; 2013 Dec 07; 250():348-52. PubMed ID: 24148569
    [Abstract] [Full Text] [Related]

  • 19. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology.
    Zawadzka M, Franklin RJ.
    Curr Opin Neurol; 2007 Jun 07; 20(3):294-8. PubMed ID: 17495623
    [Abstract] [Full Text] [Related]

  • 20. Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
    Hesp ZC, Goldstein EZ, Miranda CJ, Kaspar BK, McTigue DM.
    J Neurosci; 2015 Jan 21; 35(3):1274-90. PubMed ID: 25609641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.